ARTICLES

Simon discloses stake in shopping-mall owner Macerich

Indianapolis-based Simon Property Group Inc. said it has accumulated a 3.6-percent stake in shopping mall rival Macerich Co. and wants to buy more shares.
Read More

New type of cholesterol drug shows promise in study

The results have immediate implications for 1 million Americans who suffer mild heart attacks or chest pain each year. They may also make it easier for other experimental medicines from companies such as Eli Lilly to reach patients.
Read More

Dead celebrities show promotional staying power

With help from companies like Indianapolis-based CMG Worldwide, deceased icons like James Dean, Michael Jackson, Elvis Presley and Amelia Earhart are enjoying unprecedented success, out-earning even their former flesh-and-blood selves.
Read More

Bullard says low inflation not enough to justify zero rates

Federal Reserve Bank of St. Louis President James Bullard said market-based measures of inflation expectations have declined to low levels in recent months but have rebounded since mid-October.
Read More

U.S. employers add 214K jobs; rate falls to 5.8 percent

Employers have now added at least 200,000 jobs for nine straight months, the longest such stretch since 1995.
Read More

Job cuts to hit Rolls-Royce operations in Indianapolis

The global firm is planning 2,600 job cuts over 18 months, primarily in its aerospace division. Its Indianapolis operations, which employ about 4,500 people, are devoted mostly to civil and defense aerospace work.
Read More

Insurers' fight for customers keeps Obamacare rates down

While foes of the Affordable Care Act warned of double-digit rate increases, the costs of premiums seen so far is more modest for the new year.
Read More

Alzheimer’s drug makes Avanir potential Lilly target

Eli Lilly and Co. would be a logical acquirer for the maker of a drug that could treat agitation in Alzheimer’s patients.
Read More

Indiana Toll Road operator wins approval of bankruptcy plan

U.S. Bankruptcy Judge Pamela S. Hollis in Chicago on Tuesday granted ITR Concession Co. approval of the reorganization plan, which is supported by more than 87 percent of senior secured debtholders.
Read More

Novo, Lilly shares fall after Sanofi warns of diabetes price war

Shares in Novo Nordisk A/S, Eli Lilly and Co. and other makers of diabetes therapies sank Tuesday after Sanofi CEO Chris Viehbacher said competition on prices in the United States will hurt sales next year.
Read More